Beyond Air, Inc. Marketable Securities, Unrealized Gain (Loss)
Beyond Air, Inc. (XAIR) reported Marketable Securities, Unrealized Gain (Loss) of -$2.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2026-08-13
- Beyond Air, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2026-06-30 was -$2.00K, a 122.22% decline year-over-year.
- Beyond Air, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2025-12-31 was $13.00K.
- Beyond Air, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2025-09-30 was -$5.00K, a 105.05% decline year-over-year.
- Beyond Air, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2025-06-30 was $9.00K.
- Beyond Air, Inc. marketable securities, unrealized gain (loss) for fiscal 2025 was -$60.00K.
- Beyond Air, Inc. marketable securities, unrealized gain (loss) for fiscal 2024 was -$123.00K, a 1125.00% decline from fiscal 2023.
- Beyond Air, Inc. marketable securities, unrealized gain (loss) for fiscal 2023 was $12.00K.
- Beyond Air, Inc. marketable securities, unrealized gain (loss) for fiscal 2017 was $2.15K.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 9 month as first filed | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$2.00K 10-Q · filed 2026-08-13 | ||||
| 2025-12-31 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-13 | $8.00K derived: sum of 2 quarters · filed 2026-02-13 | $17.00K 10-Q · filed 2026-02-13 | -$1.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-09-30 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-10 | $4.00K 10-Q · filed 2025-11-10 | -$14.00K derived: sum of 3 quarters · filed 2026-08-13 | -$65.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $9.00K 10-Q · filed 2026-08-13 | -$9.00K derived: sum of 2 quarters · filed 2026-08-13 | -$60.00K derived: sum of 3 quarters · filed 2026-08-13 | $39.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26 | -$69.00K derived: sum of 2 quarters · filed 2026-06-26 | $30.00K derived: sum of 3 quarters · filed 2026-06-26 | -$60.00K 10-K · filed 2026-06-26 | |
| 2024-12-31 | -$51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-13 | $48.00K derived: sum of 2 quarters · filed 2026-02-13 | -$42.00K 10-Q · filed 2026-02-13 | $15.00K 10-Q · filed 2025-02-10 | -$66.00K derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-09-30 | $99.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-10 | $9.00K 10-Q · filed 2025-11-10 | -$15.00K derived: sum of 3 quarters · filed 2025-11-10 | -$9.00K derived: sum of 4 quarters · filed 2025-11-10 | |
| 2024-06-30 | -$90.00K 10-Q · filed 2025-08-12 | -$114.00K derived: sum of 2 quarters · filed 2025-08-12 | -$108.00K derived: sum of 3 quarters · filed 2025-08-12 | -$288.00K derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | -$24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-20 | -$18.00K derived: sum of 2 quarters · filed 2025-06-20 | -$198.00K derived: sum of 3 quarters · filed 2025-06-20 | -$123.00K 10-K · filed 2025-06-20 | |
| 2023-12-31 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-12 | -$174.00K derived: sum of 2 quarters · filed 2024-02-12 | -$99.00K 10-Q · filed 2024-02-12 | -$125.00K derived: sum of 4 quarters · filed 2024-08-06 | |
| 2023-09-30 | -$180.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-13 | -$105.00K 10-Q · filed 2023-11-13 | -$131.00K derived: sum of 3 quarters · filed 2024-08-06 | ||
| 2023-06-30 | $75.00K 10-Q · filed 2024-08-06 | $49.00K derived: sum of 2 quarters · filed 2024-08-06 | |||
| 2023-03-31 | -$26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-24 | $12.00K 10-K · filed 2024-06-24 | |||
| 2022-12-31 | $38.00K 10-Q · filed 2024-02-12 | ||||
| 2021-09-30 | $5.00K 10-Q · filed 2022-11-08 | ||||
| 2018-12-31 | $4.37K 10-Q · filed 2019-02-14 | $6.96K derived: sum of 2 quarters · filed 2019-02-14 | $13.14K 10-Q · filed 2019-02-14 | $7.23K derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-09-30 | $2.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-14 | $8.00K 10-Q · filed 2018-11-14 | $2.87K derived: sum of 3 quarters · filed 2019-08-14 | ||
| 2018-06-30 | $5.40K 10-Q · filed 2019-08-14 | $268.00 derived: sum of 2 quarters · filed 2019-08-14 | |||
| 2018-03-31 | -$5.13K 10-K · filed 2019-06-28 | ||||
| 2017-12-31 | $2.15K 10-K · filed 2019-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |